1 December 2023
Transense Technologies plc
("Transense", or the "Company")
Grant of share options to Director and employee
Transense Technologies plc, the provider of specialist sensing solutions and measurement systems, announces that it has today granted 125,000 options to acquire ordinary shares of 10 pence each in the Company ("Ordinary Shares") to an employee and a Director (the "Options").
In accordance with the Company's share scheme, the Options have an exercise price of 10 pence per Ordinary Share, being nominal value of an Ordinary Share and can be exercised after three years until the tenth anniversary of the grant. Two thirds of the Options are only exercisable if the Company's share price exceeds 150 pence per Ordinary Share for ten consecutive trading days at any time. The remaining one third of the Options are only exercisable in full if the share price exceeds 200 pence per Ordinary Share for ten consecutive trading days at any time, with none of this tranche being exercisable if the share price has not exceeded 150 pence per share for ten consecutive trading days and a pro?rata amount will be exercisable between these two share price targets.
Following these grants there are 1,567,500 unexercised share options over Ordinary Share in issue, representing approximately 9.54% of the current issued share capital of the Company.
Included in the above grant of options are 75,000 options granted to Ryan Maughan, a Director of the Company, taking his total unexercised share options to 225,000.
Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.
For further information please visit www.transense.com or contact:
| Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (CFO) | Via Walbrook PR |
| Allenby Capital (Nominated Adviser and Broker) Jeremy Porter / George Payne (Corporate Finance) Stefano Aquilino / Tony Quirke (Sales & Corporate Broking) | Tel: +44 (0)20 3328 5656 |
| Walbrook PR Tom Cooper/Nick Rome/Joe Walker | Tel: +44 (0)20 7933 8780 Transense@walbrookpr.com |
Notes to Editors:
Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, automotive (high performance and off-road) and complex machine control.
The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com
For further information please contact transense@walbrookpr.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |
| a)
| Name
| Ryan Maughan |
| 2
| Reason for the notification | |
| a)
| Position/status
| Business Development Director |
| b)
| Initial notification /Amendment
| Initial |
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
| a)
| Name
| Transense Technologies plc |
| b)
| LEI
| 2138005N52J6KKQ3EY67 |
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
| a)
| Description of the financial instrument, type of instrument | Options over Ordinary shares of 10 pence each |
| | | |
| Identification code | GB00BDHDTH21 | |
| | | |
| b)
| Nature of the transaction
| Grant of options |
| c) | Price and volume | Exercise Price(s) 10p Volume(s) 75,000 |
| d)
| Aggregated information | |
| | | |
| - Aggregated volume | As above | |
| | | |
| - Price | | |
| | | |
| e)
| Date of the transaction
| 1 December 2023 |
| f)
| Place of the transaction
| Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.